There presently are 67 Affiliate Investigators (Als) of the NORC (Table 1) representing a diversity of divisions, departments, and schools throughout the University of Washington (UW) system (see Table 2). Although most of the investigators are in clinical departments, the UW is unique in that many of its basic scientists actually have their primary appointments in clinical departments. There has been a longstanding interest in several aspects of nutrition and obesity at the UW. However, over the past several years, Als have tended to focus their research in the following major areas: 1. Body Weight Regulation and Obesity 2. Adipose Tissue Biology and Inflammation 3. Lipids and Atherosclerosis 4. Diabetes

Public Health Relevance

Obesity and associated metabolic disorders have emerged as leading health problems in the US and other westernized countries. Compounding this problem is a lack of effective nonsurgical treatments for obesity, which reflects deficiencies in our understanding of underlying causes. The NORC offers valuable resources to a large group of researchers at UW investigating nutrition, obesity and associated disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK035816-26
Application #
8385929
Study Section
Special Emphasis Panel (ZDK1-GRB-2 (M3))
Program Officer
Evans, Mary
Project Start
1996-12-01
Project End
2017-06-30
Budget Start
2012-07-20
Budget End
2013-06-30
Support Year
26
Fiscal Year
2012
Total Cost
$1,294,483
Indirect Cost
$512,411
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Du, Dan; Gu, Haiwei; Djukovic, Danijel et al. (2018) Multiplatform Metabolomics Investigation of Antiadipogenic Effects on 3T3-L1 Adipocytes by a Potent Diarylheptanoid. J Proteome Res 17:2092-2101
Vaisar, Tomáš; Couzens, Erica; Hwang, Arnold et al. (2018) Type 2 diabetes is associated with loss of HDL endothelium protective functions. PLoS One 13:e0192616
Anderson, Lindsey J; Tamayose, Jamie M; Garcia, Jose M (2018) Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. Mol Cell Endocrinol 464:65-74
Han, Seung Jin; Boyko, Edward J; Kim, Soo Kyung et al. (2018) Association of Thigh Muscle Mass with Insulin Resistance and Incident Type 2 Diabetes Mellitus in Japanese Americans. Diabetes Metab J 42:488-495
Wander, Pandora L; Hayashi, Tomoshige; Sato, Kyoko Kogawa et al. (2018) Design and validation of a novel estimator of visceral adipose tissue area and comparison to existing adiposity surrogates. J Diabetes Complications 32:1062-1067
Bornfeldt, Karin E; Kramer, Farah; Batorsky, Anna et al. (2018) A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis. Am J Pathol 188:343-352
Haenisch, Michael; Treuting, Piper M; Brabb, Thea et al. (2018) Pharmacological inhibition of ALDH1A enzymes suppresses weight gain in a mouse model of diet-induced obesity. Obes Res Clin Pract 12:93-101
Bentsen, Marie Aare; Mirzadeh, Zaman; Schwartz, Michael W (2018) Revisiting How the Brain Senses Glucose-And Why. Cell Metab :
Faber, Chelsea L; Matsen, Miles E; Velasco, Kevin R et al. (2018) Distinct Neuronal Projections From the Hypothalamic Ventromedial Nucleus Mediate Glycemic and Behavioral Effects. Diabetes 67:2518-2529
Goh, Charlene E; Mooney, Stephen J; Siscovick, David S et al. (2018) Medical facilities in the neighborhood and incidence of sudden cardiac arrest. Resuscitation 130:118-123

Showing the most recent 10 out of 601 publications